Sema4 Holdings Corp.
If you purchased Sema4 Holdings Corp. securities and would like to join the action, please click "Join This Action" below.
SEMA4 (SMFR) STOCK INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE MERGER OF SEMA4 HOLDINGS CORP. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – SMFR
January 18, 2022.
New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Sema4 Holdings Corp. (NASDAQ: SMFR) and GeneDx, Inc. is fair to Sema4 shareholders.
The investigation concerns whether Sema4 and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Sema4 shareholders; and (2) disclose all material information necessary for Sema4 shareholders to adequately assess and value the merger consideration. On behalf of Sema4 shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.